Roma chilengi
Roma chilengi
Chief Scientific Officer, Centre for Infectious Disease Research in Zambia
Verified email at - Homepage
Cited by
Cited by
Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised …
S Rts
Lancet 386 (9988), 31-45, 2015
Efficacy and safety of the RTS, S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites
RTS, S Clinical Trials Partnership (2014)
PLoS medicine 11 (7), e1001685, 2014
Humoral Responses to Plasmodium falciparum Blood-Stage Antigens and Association with Incidence of Clinical Malaria in Children Living in an Area of Seasonal …
I Nebie, A Diarra, A Ouedraogo, I Soulama, EC Bougouma, AB Tiono, ...
Infection and immunity 76 (2), 759-766, 2008
Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children
D Dodoo, A Aikins, KA Kusi, H Lamptey, E Remarque, P Milligan, ...
Malaria journal 7 (1), 1-11, 2008
Composition, training needs and independence of ethics review committees across Africa: are the gate-keepers rising to the emerging challenges?
A Nyika, W Kilama, R Chilengi, G Tangwa, P Tindana, P Ndebele, ...
Journal of medical ethics 35 (3), 189-193, 2009
A phase 2b randomized, controlled trial of the efficacy of the GMZ2 malaria vaccine in African children
SB Sirima, B Mordmüller, P Milligan, UA Ngoa, F Kironde, F Atuguba, ...
Vaccine 34 (38), 4536-4542, 2016
Menstrual hygiene management in rural schools of Zambia: a descriptive study of knowledge, experiences and challenges faced by schoolgirls
J Chinyama, J Chipungu, C Rudd, M Mwale, L Verstraete, C Sikamo, ...
BMC public health 19, 1-10, 2019
Factors influencing vaccine acceptance and hesitancy in three informal settlements in Lusaka, Zambia
M Pugliese-Garcia, LW Heyerdahl, C Mwamba, S Nkwemu, R Chilengi, ...
Vaccine 36 (37), 5617-5624, 2018
Hepatitis B virus infection as a neglected tropical disease
GA O’Hara, AL McNaughton, T Maponga, P Jooste, P Ocama, R Chilengi, ...
PLoS neglected tropical diseases 11 (10), e0005842, 2017
Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambarene, Gabon
B Mordmüller, K Szywon, B Greutelaers, M Esen, L Mewono, C Treut, ...
Vaccine 28 (41), 6698-6703, 2010
Clinical research in resource-limited settings: enhancing research capacity and working together to make trials less complicated
TA Lang, NJ White, TT Hien, JJ Farrar, NPJ Day, R Fitzpatrick, BJ Angus, ...
PLoS neglected tropical diseases 4 (6), e619, 2010
Safety and Immunogenicity of Heterologous Prime-Boost Immunisation with Plasmodium falciparum Malaria Candidate Vaccines, ChAd63 ME-TRAP and MVA ME …
C Ogwang, M Afolabi, D Kimani, YJ Jagne, SH Sheehy, CM Bliss, ...
PloS one 8 (3), e57726, 2013
Data-driven quality improvement in low-and middle-income country health systems: lessons from seven years of implementation experience across Mozambique, Rwanda, and Zambia
BH Wagenaar, LR Hirschhorn, C Henley, A Gremu, N Sindano, ...
BMC health services research 17, 65-75, 2017
HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria
JP Van Geertruyden, M Mulenga, L Mwananyanda, V Chalwe, ...
The Journal of infectious diseases 194 (7), 917-925, 2006
Safety and immunogenicity of the malaria vaccine candidate MSP3 long synthetic peptide in 12–24 months-old Burkinabe children
SB Sirima, AB Tiono, A Ouédraogo, A Diarra, AL Ouédraogo, JB Yaro, ...
PloS one 4 (10), e7549, 2009
Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya
SH Hodgson, E Juma, A Salim, C Magiri, D Njenga, S Molyneux, ...
Malaria journal 14 (1), 1-12, 2015
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations
D Kimani, YJ Jagne, M Cox, E Kimani, CM Bliss, E Gitau, C Ogwang, ...
Molecular Therapy 22 (11), 1992-2003, 2014
Assessing capacity and readiness to manage NCDs in primary care setting: Gaps and opportunities based on adapted WHO PEN tool in Zambia
W Mutale, S Bosomprah, P Shankalala, O Mweemba, R Chilengi, ...
PloS one 13 (8), e0200994, 2018
Association of maternal immunity with rotavirus vaccine immunogenicity in Zambian infants
R Chilengi, M Simuyandi, L Beach, K Mwila, S Becker-Dreps, ...
PloS one 11 (3), e0150100, 2016
Engaging diverse communities participating in clinical trials: case examples from across Africa
A Nyika, R Chilengi, D Ishengoma, S Mtenga, MA Thera, MS Sissoko, ...
Malaria Journal 9, 1-11, 2010
The system can't perform the operation now. Try again later.
Articles 1–20